The company's purpose is to conduct preclinical and clinical research, discovery and development of new medicines, combinations of medicines, diagnostics and biomarkers for antibody-based therapies and small molecules for the treatment of cancer, immune system diseases and potentially other disease areas. The company may conduct all business and take all measures that are suitable to promote the company's purpose directly or indirectly, such as acquiring, managing, using, encumbering and disposing of undertakings of all kinds, real estate and intellectual property rights in Switzerland and abroad, establishing branches and agencies, granting loans, managing capital and providing guarantees in favor of affiliated companies. The company may provide direct or indirect financing to third parties or companies in which it is directly or indirectly involved, as well as to direct or indirect shareholders or companies in which such parties are directly or indirectly involved, whether through loans and/or other financing, with or without consideration. The company may provide security of any kind for its own liabilities or the liabilities of the aforementioned persons, including through pledges, assignments, fiduciary transfers, guarantees of any kind or through offset obligations, with or without consideration, even if such financing, security or guarantees are in the exclusive interest of third parties or companies in which it is directly or indirectly involved, or of direct or indirect shareholders or companies in which such parties are directly or indirectly involved.
Outbound Leads by COHAGA